Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes
Clinical trial NCT02362412 · COMPLETED
Trial details
- NCT number
- NCT02362412
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-18
- Primary completion
- 2016-02-06
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.